Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism (original) (raw)

• Carson, D. & Raz, E. Oligonucleotide adjuvants for T helper 1 Th1 -specific vaccination. J. Exp. Med. 186, 1621–1622. (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Krieg, A.M., Yi, A.K., Schorr, J. & Davis, H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6, 23–27 (1998).
  Article CAS PubMed Google Scholar
• Shimada, S. et al. Antitumor activity of the deoxyribonucleic acid fraction of Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J. Natl. Cancer Inst. 74, 681–688 (1985).
  CAS PubMed Google Scholar
• Tokunaga, T. et al. Antitumor activity of the deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72, 955–962 (1984).
  CAS PubMed Google Scholar
• Yamamoto, S. et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J. Immunol. 148, 4072–4076 (1992).
  CAS PubMed Google Scholar
• Martin-Orozco, E. et al. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int. Immunol. 11, 1111–1118 ( 1999).
  Article CAS PubMed Google Scholar
• Krieg, A.M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549 ( 1995).
  Article CAS PubMed Google Scholar
• Lipford, G.B. et al. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340–2344 (1997).
  Article CAS PubMed Google Scholar
• Sato, Y. et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352–354 (1996).
  Article CAS PubMed Google Scholar
• Corr, M., Lee, D.J., Carson, D.A. & Tighe, H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555–1560. ( 1996).
  Article CAS PubMed Google Scholar
• Roman, M. et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849–854 (1997).
  Article CAS PubMed Google Scholar
• Horner, A.A. et al. Immunostimulatory DNA is a potent mucosal adjuvant. Cell. Immunol. 190, 77–82 ( 1998).
  Article CAS PubMed Google Scholar
• Chu, R.S., Targoni, O.S., Krieg, A.M., Lehmann, P.V. & Harding, C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 Th1 immunity. J. Exp. Med. 186, 1623–1631 ( 1997).
  Article CAS PubMed PubMed Central Google Scholar
• Davis, H.L. et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870–876 (1998).
  CAS PubMed Google Scholar
• Keene, J.-A. & Foreman, J. Helper activity is required for the in vivo generation of cytotoxic lymphocytes. J. Exp. Med. 155, 768–782 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Mitchison, N.A. & O' Malley, C. Three-cell-type cluster of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17, 1579–1583 (1987).
  Article CAS PubMed Google Scholar
• Bennett, S.R.M. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393, 478–480 (1998).
  Article CAS PubMed Google Scholar
• Ridge, J.P., Di Rosa, F. & Matzinger, P. A conditioned dendritic cell can be a bridge between CD4+ T-helper and a T-killer cell. Nature 393, 474–478 (1998).
  Article CAS PubMed Google Scholar
• Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R. & Melief, C.J.M. T-cell help for cytotoxic lymphocytes is mediated by CD40–CD40L interactions. Nature 393, 480–483 (1998).
  Article CAS PubMed Google Scholar
• Lin, M.S. & Chen, Y.W. B cell differentiation. II. Isotype potential of a single B cell. Cell. Immunol. 150, 343–352 (1993).
  Article CAS PubMed Google Scholar
• Porgador, A., Snyder, D. & Gilboa, E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156, 2918– 2926 (1996).
  CAS PubMed Google Scholar
• Lanzavecchia, A. License to kill. Nature 393, 413– 414 (1998).
  Article CAS PubMed Google Scholar
• Harding, F.A. & Allison, J.P. CD28–B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177, 1791 –1796 (1993).
  Article CAS PubMed Google Scholar
• Grewal, I.S. & Flavell, R.A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153, 85–106 (1996).
  Article CAS PubMed Google Scholar
• Sigal, L.J., Reiser, H. & Rock, K.L. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J. Immunol. 161, 2740–2745 (1998).
  CAS PubMed Google Scholar
• Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13, 251–276 (1995).
  Article CAS Google Scholar
• Jakob, T., Walker, P.S., Krieg, A.M., Udey, M.C. & Vogel, J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042–3046 (1998).
  CAS PubMed Google Scholar
• Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243–246 ( 1995).
  Article CAS PubMed Google Scholar
• Shen, Z., Reznikoff, G., Dranoff, G. & Rock, K. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723– 2730 (1997).
  CAS PubMed Google Scholar
• Reis e Souza, C. & Germain, R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182, 841–851 (1995).
  Article Google Scholar
• Pfeifer, J.D. et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 359–362 (1993).
• Gromme, M. et al. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. USA 96, 10326– 10331 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Reiss, M. Transforming growth factor-beta and cancer: a love–hate relationship? Oncol. Res. 9, 447–457 (1997).
  CAS PubMed Google Scholar
• Botti, C., Seregni, E., Ferrari, L., Martinetti, A. & Bombardieri, E. Immunosuppressive factors: role in cancer development and progression. Int. J. Biol. Markers 13, 51–69 (1998).
  Article CAS PubMed Google Scholar
• Korkolopoulous, P., Kaklamanis, L., Pezzella, F., Harris, A.L. & Gatter, K.C. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Brit. J. Cancer 73, 148–153 (1996).
  Article Google Scholar
• Seliger, B. et al. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes. Exp. Hematol. 24, 1275–1279 ( 1996).
  CAS PubMed Google Scholar
• Dejardin, E. et al. Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells. Oncogene 16, 3299–3307 ( 1998).
  Article CAS PubMed Google Scholar